M. D. Anderson Symptom Inventory - Ovarian Cancer



Status:Completed
Conditions:Ovarian Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:8/3/2018
Start Date:December 30, 2009
End Date:July 18, 2018

Use our guide to learn which trials are right for you!

M. D. Anderson Symptom Inventory - Ovarian Cancer: Development and Validation in Patients With Ovarian Cancer

Objectives:

The objective of this study is to delineate and measure the symptom burden experienced by
patients with ovarian cancer.

The Primary Aim is to develop and validate an ovarian-cancer module of the M. D. Anderson
Symptom Inventory (MDASI-Ovarian Cancer) to measure the severity of multiple symptoms and the
impact of these symptoms on daily functioning in patients with ovarian cancers.

The Secondary Aims are:

To develop a detailed description of symptom severity and interference with daily activities
experienced by patients with ovarian cancer; To assess the impact of symptom severity on
standard functioning and quality of life (QOL) measures, including Eastern Cooperative
Oncology Group Performance Status (ECOG PS), Functional Assessment of Cancer Therapy-Ovary
(FACT-O), and a single-item QOL scale, in patients with ovarian cancer; To define the
qualitative symptom burden of patients with ovarian cancer receiving various treatments.

PART 1:

Interview:

If you agree to take part in this study, you will be interviewed about what it is like to
have ovarian cancer and any symptoms that you may have experienced. This will be a 1-on-1
interview with the study doctor or a member of the study staff. It will take place during 1
of your regularly scheduled, standard of care clinic visit and should take about 30 minutes
to complete.

The interview will be digitally recorded. The electronic recording of the interview will be
given a code number and stored on a password-protected computer at M. D. Anderson. No
identifying information will be directly linked to your interview recording. Only the
researcher in charge of the computer will have access to the code numbers and be able to link
the interview recording to you.

Questionnaires:

After the interview, you will also complete a symptom questionnaire, a quality-of-life
questionnaire, and a demographic questionnaire that asks questions about your age, race, and
marital status. You will complete the questionnaires after the interview during the same
clinic visit. It should take about 10 minutes to complete all 3 questionnaires.

You should contact the study doctor or study nurse right away if at any time you are
experiencing severe, troublesome, or intolerable symptoms. You should also remember to rate
them on the symptom questionnaire.

The questionnaires will also be given a code number and stored in a locked file cabinet at MD
Anderson. No identifying information will be directly linked to your questionnaires. Only the
researcher in charge of the study will have access to the code numbers and be able to link
the questionnaires to you.

Length of Study:

After you have completed the interview and the questionnaires, your participation on this
study will be over.

Additional Information:

Any information about your symptoms that is collected as part of this study is for research
purposes only. All study materials, including the interview recording and questionnaires,
will only be used for the purposes of this study and will be destroyed after the study
results have been reported.

If you rate a symptom as severe on the symptom questionnaire, a study staff member will ask
you if you have already told, or plan to tell your regular care doctor or nurse about the
symptom. If you have not already told you regular care doctor or nurse, a study staff member
will tell your regular care doctor or nurse about the symptom for you.

This is an investigational study.

Up to 15 participants will take part in this study. All will be enrolled at MD Anderson.

PART 2:

Questionnaires:

If you agree to take part in this study, you will complete the following:

1. A symptom questionnaire, 2 quality-of-life questionnaires, and a demographic
questionnaire that asks questions about your age, race, and marital status. It should
take about 20 minutes to complete all 4 questionnaires.

2. About 1 to 5 days after you complete the first set of questionnaires, you will be asked
to complete a questionnaire either through phone interview with the study staff or
through a mail-in survey . If you complete the questionnaire by mail-in survey, the
study staff will give you a copy of the questionnaire and a stamped pre-addressed
envelope. The questionnaire will take 5-10 minutes to complete.

You should contact the study doctor or study nurse right away if at any time you are
experiencing severe, troublesome, or intolerable symptoms. You should also remember to rate
them on the symptom questionnaire.

The questionnaires will be given a code number and stored in a locked file cabinet at M. D.
Anderson. No identifying information will be directly linked to your questionnaires. Only the
researcher in charge of the study will have access to the code numbers and be able to link
the questionnaires to you.

Opinion Questionnaire:

If you are one of the first 20 patients enrolled in the study, you will be asked questions
about your opinion of the symptom questionnaire. For example, you will be asked if the
symptom questionnaire was easy to understand and complete, and if there were any other
questions that should be included. The study staff will use your opinion to decide if changes
should be made to the questionnaire or if important symptom questions are missing from the
questionnaire. This questionnaire should take about 5 minutes to complete.

Length of Study:

After you have completed the questionnaires, your participation on this study will be over.

Additional Information :

Any information about your symptoms that is collected as part of this study is for research
purposes only. The questionnaires will only be used for the purposes of this study and will
be destroyed after the study results have been reported.

If you rate a symptom as severe on the symptom questionnaire, a study staff member will ask
you if you have already told, or plan to tell your regular care doctor or nurse about the
symptom. If you have not already told you regular care doctor or nurse, a study staff member
will tell your regular care doctor or nurse about the symptom for you.

This is an investigational study.

Up to 128 participants will take part in this study. All will be enrolled at MD Anderson and
Lyndon B. Johnson General Hospital.

Inclusion Criteria:

1. Female patients 18 years of age or older.

2. Able to speak and read English.

3. Having a diagnosis of high grade invasive epithelial ovarian cancer, peritoneal cancer
or fallopian tube cancer confirmed by pathological analysis.

4. Being followed at M D Anderson Cancer Center and Lyndon B. Johnson General Hospital
(LBJ Hospital).

5. Has consented to participate.

6. Has not received any current cancer treatment or prior chemotherapy in the last 30
days (phase 2 subset of 40 patients only)

Exclusion Criteria:

1) Having a medical condition or impaired performance status that would preclude
participation in the study.
We found this trial at
2
sites
1515 Holcombe Blvd
Houston, Texas 77030
 713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas 77026
?
mi
from
Houston, TX
Click here to add this to my saved trials